Catalyst Wire Dossier Catalyst Wire Dossier

Factor IX-albumin fusion protein

recombinant coagulation factor IX albumin fusion protein · CSL Behring
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Factor IX-albumin fusion protein, covering 2012-01-31 to 2012-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B [Phase 1]

See pricing